SR

Srinivasa Rao Kandula

Active Director Director DIN 02461795
DIN 02461795 First appointment Jun 2024 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Kandula

Data last updated:

Srinivasa Rao Kandula is a Director at Acro Bio Sciences Private Limited (since 2024). The company operates in Business Services.

DIN 02461795
Primary Designation Director
Industry Business Services
First Appointment 24 Jun 2024
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acro Bio Sciences Private Limited U74999TG2018PTC122114
Director24 Jun 20242018Active

Board colleagues of Srinivasa Rao Kandula

NameDINCompanyDesignation
Mahendra Singh Bondili01149994Acro Bio Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Acro Bio Sciences Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Kandula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Kandula

Srinivasa Rao Kandula currently holds 1 directorship: Acro Bio Sciences Private Limited (Director, since 24 Jun 2024).

Srinivasa Rao Kandula was first appointed on 24 Jun 2024 as Director at Acro Bio Sciences Private Limited.

The current boards of Srinivasa Rao Kandula's companies include Mahendra Singh Bondili (Acro Bio Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available